Trial intelligence / Profile preview

Pharmacodynamic comparison of oral P2Y12 inhibitor loading strategies during transition from cangrelor

2015-005071-25Phase 3Active

Sponsor
Universitäts-Herzzentrum Freiburg-Bad Krozingen
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in coronary arteriosclerosis comparing Prasugrel loading after cangrelor, Ticagrelor loading after cangrelor and Clopidogrel loading after cangrelor (3 arms). Started Nov 2015; status: active.

02

Drugs

prasugrelticagrelorclopidogrel
03

Conditions

coronary arteriosclerosis

Beyond the preview

Go deeper on 2015-005071-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-005071-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call